1/64
Looks like no tags are added yet.
Chemotherapy
drugs that target living cells and microbes
Antimicrobials were mostly obtained through
consumption of plants and fermented products
Paul Ehrlich
scanned through 600 arsenic compounds to find cure for syphilis without killing host
Syphilis compound was derived from
Treponema pallidum and established modern drug discovery methods
Joseph Klarer, Fritz Mietzch, and Gerhard Domagk
used synthetic dye, prontosil, to treat strep infections
The first synthetic antimicrobial was
Prontosil; opened door for all "sulfa" drugs
Alex Fleming
accidentally discovered antibiotic from Penicillum
Penicillum
1st natural antibiotic
Narrow Spectrum of Chemotherapy Drugs
BEST CHOICE; targets specific group of microbes
Broad Spectrum of Chemotherapy Drugs
targets wide variety
Downside to Broad Spectrum
superinfection
Superinfection
Broad-spectrum antibiotics kill protective cells
Dosage
concentration given in a certain time period
Optimal dosage allows
high drug efficacy with low adverse effects for patient
factors considered when dosing
mass, metabolization, half-life, dose dependent, time dependent
What can aid in optimal dosing?
Route of administration

fastest response time
intravenous
How can some drugs interact with each other?
Synergistic (ex. Trimethoprint + Bactrim) or Antagonistic (ex. Rifampin + birth control)
Selective toxicity
inhibiting/killing microbe but not harm to host
Inhibitors of Cell Wall Synthesis: Prominent drugs: β-lactams:
Presence of lactam ring; blocks cross-linking of peptide chains in new peptidoglycan; Penicillins (narrow), Cephalosporins (narrow except 3, 4, 5 generations; 5= MRSA), Monobactams (narrow), and Carbapenems (broad)
Inhibitors of Cell Wall Synthesis: Prominent Cell Wall drugs: Vancomycin
binds to end of peptide chain to block subunits from adding to peptidoglycan backbone; narrow spectrum against gram-positive bacteria
Inhibitors of Cell Wall Synthesis: Prominent Cell Wall drugs: Bacitracin
Derived from B. subtilis; blocks peptidoglycan precursors from getting to wall; broad spectrum against gram positive and negative
Inhibitors of Protein Synthesis: Prominent Cell Wall drugs: Aminoglycosides
Bind to 30S subunit of ribosome and impair "proofreading" ability; ex. Streptomycin, gentamycin, neomycin; Broad spectrum
Inhibitors of Protein Synthesis: Prominent Cell Wall drugs: Tetracyclines
block association of tRNA with ribosome; broad spectrum
Inhibitors of Protein Synthesis: Prominent Cell Wall drugs: Macrolides
binds to 50S subunit & inhibits peptide bond formation in specific combos of amino acids; Ex. erythromycin, azithromycin, lincomycin (narrow spectrum); broad spectrum
Inhibitors of Protein Synthesis: Prominent Cell Wall drugs: Macrolides: Chloramphenicol
structurally diff. than macrolides but same mechanism of action; Broad spectrum
Inhibitors of Membrane Function: Polymyxins
target LPS and membranes in gran (-), wounds and systemic infections
Inhibitors of Membrane Function: Daptomycin
narrow spectrum; target gram (+)/ MRSA
Inhibitors of Nucleic Acid Synthesis: Metronidazole
infections by G.lamblia, E.histolyca, T.vaginalis
Inhibitors of Nucleic Acid Synthesis: Rifampin
blocks RNA activity; toxic to liver; narrow spectrum; Mycobacterium tuberculosis
Inhibitors of Nucleic Acid Synthesis: Fluoroquinolones
inhibit enzyme and replication; selective toxicity but many side effects; broad spectrum
Inhibitors of Metabolic Pathways: Antimetabolites
competitive inhibitors of enzymes to stop certain pathways
Inhibitors of Metabolic Pathways: Sulfonamides (sulfa drugs)
halts folic acid synthesis and production of pyrimidines & purines; Broad spectrum
Inhibitors of Metabolic Pathways: Trimethoprim
inhibits later stage of folic acid synthesis; Sulfamethoxazale and Trimethoprim are commonly used in combo to boost effect; Broad spectrum
Inhibitors of Metabolic Pathways: Isoniazid
specific toxicity for mycobacteria to block synthesis of mycolic acid; Narrow spectrum
Inhibitors of ATP Synthase: Diarylquinolines
inhibits mycobacterial growth; exact mechanisms is unknown but evidence shows interference with ATP synthase and reducing available ATP
Antifungal Drugs: Mechanism of Action
disruption of sterol and membrane
Antifungal Drugs: Prominent drugs
Imidazoles, Triazoles, and Allylamines
Antifungal Drugs: Other Mechanism of Action: Polyenes
Bind to ergosterol and create pore in membrane
Antifungal Drugs: Other Mechanism of Action: Echinocandins
Inhibit glucan synthesis
Antifungal Drugs: Other Mechanism of Action: Polyoxins and Nikkomycins
Inhibit chitin synthesis
Antifungal Drugs: Other Mechanisms of Action: Griseofulvin
Disrupt mitosis
Antiprotozoan Drugs: Mechanism of Action
Inhibition of metabolites and DNA synthesis
Antiprotozoan Drugs: Prominent drugs: Atovaquone
inhibits electron transport
Antiprotozoan Drugs: Prominent drugs: Proquanil
inhibits folic acid synthesis
Antiprotozoan Drugs: Prominent drugs: Metronidazole
inhibits DNA synthesis; Giardia lamblia, Entamoeba histolytica, and Trichomonas vaginalis
Antihelminthic Drugs
Achieving selective toxicity is challenging
Antihelminthic Drugs: Mechanism of Action
Inhibition of microtubule formation and block of neural transmission
Antihelminthic Drugs: Prominent drugs: Mebendazole
inhibition of microtubule
Antihelminthic Drugs: Prominent drugs: Ivermectin
blocks neural transmission
Antiviral Drugs: Mechanism of Action
inhibiting nucleic acid synthesis (ex. acyclovir- Herpes virus infection)
Antiviral Drugs: Other Mechanism of Action: Ex. Olestamivir (Tamiflu)
inhibition of neuraminidase that aids in release of viral particles from host cell
Antiretroviral therapy (HIV)
includes "cocktail" of antivirals to target multiple processes
Antibiotic Resistance
Arises from increased selective pressure (e.g. evolution)
Selective pressure increased through:
Misuse and inappropriate use of antimicrobials, subtherapeutic dosage, and patient noncompliance
Resistance genes are obtained through:
Horizontal and vertical transfer
Antibiotic Resistance: Drug modification
-β-lactamases hydrolyze lactam bond
-Pathogens will develop special membrane pump to get rid of drugs
Antibiotic Resistance: Target modification
-LPS structure- polymyxins
-RNA polymerase- Rifampin
Antibiotic Resistance: Target overproduction
Overproduction of metabolite to outnumber drug compounds
Antibiotic Resistance: Target mimicry
M. tuberculosis produces pentapeptides to mimic DNA and binds to fluoroquinolones
Testing for Efficacy: Kirby-Bauer Method
Disk diffusion test to examine degree of susceptibility/resistance
Testing for Efficacy: Minimum Inhibitor Concentration
Examines minimum amount to inhibit/kill microbe
multi-drug resistant microbes
superbugs; one or more resistance mechanisms
cross resistance
one mechanism resists multiple antimicrobial drugs
MDR’s: ESKAPE
E. faecium, S.aureus, K.pneumoniae, A. baumanni, P.aeruginosa, Enterobacter